close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ketamine/Assisted Therapy

Recent news which mentions Ketamine/Assisted Therapy

EXCLUSIVE: Mindbloom's Mastermind Series, A Psychedelic Therapy Program For Heartbreak, Burnout & Parallel Challenges
Tags Mindbloom Management Markets
From Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Tickers AWKNF CMPS
Tags Markets AWKNF Legal
From Benzinga
Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio
Tags Market News Contracts Cannabis
From Benzinga
Psychedelics Firm Optimind Pharma Sustains Growth Plan Rollout With New Acquisition
Tags Optimind Pharma Corp News Management
From Benzinga
PsychMD's Nationwide, Safe-Supplied AI-Driven Ketamine Therapy With US Vets In Mind
Tags virtual reality News Management
From Benzinga
Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans
Tags Markets Ketamine/Assisted Therapy Psychedelics
From Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
Tickers AWKNF
Tags News Penny Stocks Markets
From Benzinga
Joint Venture Partnership Expands Access To Psychedelics Therapy For Some 50K Patients
Tickers RVLWF
Tags News Cannabis RVLWF
From Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
Tickers ATAI CMPS DMTTF MNMD
Tags Benzinga DMTTF Ketamine/Assisted Therapy
From Benzinga
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
Tickers AWKNF
Tags Market News Interview Cannabis
From Benzinga
EXCLUSIVE: NYC's Premier Ketamine Therapy Provider Nushama Talks Integration, Safety & Holistic Care
Tags Psychedelics Ketamine/Assisted Therapy Benzinga
From Benzinga
Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status
Tickers AWKNF
Tags Cannabis alcohol use disorder Market News
From Benzinga
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain
Tickers CYBN
Tags Ketamine/Assisted Therapy Psychedelics Markets
From Benzinga
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Tickers AWKNF
Tags AWKNF UK National Health Service Markets
From Benzinga
Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of 'Freedom' Program
Tickers AMZN META TECH
Tags Markets Offerings News
From Benzinga
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
Tickers AWKNF
Tags Norway News Penny Stocks
From Benzinga
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
Tickers AWKNF
Tags Market News alcohol use disorder Health Care
From Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
Tickers ATAI CMPS
Tags Cannabis ATAI Market News
From Benzinga
Psychedelic-Assisted Psychotherapy And Telehealth Platforms Merge To Enhance Treatment Options
Tags Reconscious Medical Cannabis Market News
From Benzinga
Florida Ketamine Therapy Provider Launches Non Profit To Offer Affordable Psychedelic Treatments
Tags Benzinga Psychedelics Ketamine/Assisted Therapy
From Benzinga
EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC
Tickers AWKNF NYC
Tags AWKNF NYC Markets
From Benzinga
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Tickers IWINF
Tags Benzinga Psychedelics Ketamine/Assisted Therapy
From Benzinga
At Home-Ketamine Therapy Platform: What's It All About?
Tags Nue Life Health Offerings Markets
From Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
Tickers PHRRF
Tags Global LTS LOHMANN Therapie/Systeme AG News
From Benzinga
Awakn Life Sciences: Business And Corporate Update For Psychedelics Biotech
Tickers AWKNF
Tags Licensing and Access Pathway application News Global
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today